Drug Development advanced
Peptide Ophthalmic Drug Development
Development of peptide therapeutics for eye diseases including formulation challenges.
By Encyclopeptide Editorial | 1 min read
ophthalmic drug-development formulation clinical-trials eye-disease
Overview
Developing peptide therapeutics for ophthalmic applications requires overcoming unique challenges related to ocular anatomy.
Formulation Challenges
- Corneal epithelium barrier
- Tear film dilution
- Nasolacrimal drainage
- Enzymatic degradation
Delivery Strategies
- Topical: Eye drops, gels, inserts
- Intravitreal: Direct retinal delivery
- Periocular: Subconjunctival injection
- Systemic: For posterior segment disease
Chemical Identity
| Property | Value |
|---|---|
| Name | Peptide Ophthalmic Drug Development |
| Category | Drug Development |
References
- Encyclopeptide Database. “Peptide Ophthalmic Drug Development” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Peptide Ophthalmic Drug Development with interactive quizzes on Wikipept.
Take a Quiz on Wikipept